Home
Two Seas Capital reported a 5.8% stake in Adaptimmune Therapeutics ADAPY · 89,010,876 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.8%
- Last report
- First report
- Shares held
- 89,010,876 sh
- Class
- Ordinary Shares, par value GBP 0.001 per share
- Holder
- Two Seas Capital
- Event date
- 24/12/31
- Filed
- 25/02/14
First 5%+ report · 5.8% stake
Adaptimmune Therapeutics trades, last 26 weeks
What else happened in Adaptimmune Therapeutics around then
Filed or reported within 30 days of the trade day · 24/12/01~25/01/30Two Seas Capital's other 5% stake reports
- Two Seas Capital
5% stakeSable Offshore
5% stakeSable Offshore
SOC
5.4% stake
8,377,636 sh
5.4% stake
Filed 08/14
- Two Seas Capital
5% stakeCalumet
5% stakeCalumet
CLMT
7.5% stake
6,619,708 sh
7.5% stake
Filed 08/14
- Two Seas Capital
5% stakeQuantum
5% stakeQuantum
QMCO
6.3% stake
2,488,535 sh
6.3% stake
Filed 08/14
- Two Seas Capital
5% stakeNektar Therapeutics
5% stakeNektar Therapeutics
NKTR
9.1% stake
3,092,234 sh
9.1% stake
Filed 08/14
- Two Seas Capital
5% stakePAVmed
5% stakePAVmed
PAVM
9.99% stake
657,219 sh
9.99% stake
Filed 05/15
